Sotac Pharmaceuticals Limited (NSE:SOTAC)
India · Delayed Price · Currency is INR 125.00
+0.80 (0.64%)
At close: Feb 12, 2026
Sotac Pharmaceuticals Revenue
Sotac Pharmaceuticals had revenue of 185.05M INR in the quarter ending September 30, 2025, a decrease of -32.33%. This brings the company's revenue in the last twelve months to 846.72M, down -19.27% year-over-year. In the fiscal year ending March 31, 2025, Sotac Pharmaceuticals had annual revenue of 1.00B, down -3.57%.
Revenue (ttm)
846.72M
Revenue Growth
-19.27%
P/S Ratio
1.63
Revenue / Employee
6.67M
Employees
127
Market Cap
1.38B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.00B | -37.09M | -3.57% |
| Mar 31, 2024 | 1.04B | 264.82M | 34.18% |
| Mar 31, 2023 | 774.83M | 43.32M | 5.92% |
| Mar 31, 2022 | 731.52M | 243.09M | 49.77% |
| Mar 31, 2021 | 488.43M | 202.40M | 70.76% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bilcare | 7.57B |
| Bal Pharma | 3.11B |
| Parnax Lab | 2.05B |
| Ambalal Sarabhai Enterprises | 1.97B |
| Lactose (India) | 1.37B |
| Astonea Labs | 1.17B |
| Aayush Wellness | 1.11B |
| Coral Laboratories | 889.77M |